Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02412813

LEGION™ Revision Metal Hypersensitivity Study

A Prospective, Randomized, Multi-Center, Metal Hypersensitivity Study Comparing OXINIUM and Cobalt Chrome Femoral Components in Failed Total Knee Arthroplasty

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Smith & Nephew, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized, multi-center, metal hypersensitivity study comparing OXINIUM and cobalt chrome femoral components in subjects with failed total knee arthroplasty (TKA).

Detailed description

A total of 230 subjects will be randomized (1:1) to receive either an OXINIUM or cobalt chrome femoral components as part of their LEGION revision procedure. The objective of this study is to assess a lower serum metal ion concentration level in at least one of the three major mLTTs (Co, Cr or Ni) over 5 years in subjects receiving OXINIUM versus Cobalt Chrome femoral components as part of the LEGION Revision Total Knee System.

Conditions

Interventions

TypeNameDescription
DEVICELEGION OXINIUMInvestigational Group
DEVICELEGION Cobalt ChromeControl Group

Timeline

Start date
2016-01-01
Primary completion
2025-04-01
Completion
2025-04-01
First posted
2015-04-09
Last updated
2016-03-09

Locations

3 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02412813. Inclusion in this directory is not an endorsement.